TABLE 4.
Surgical postoperative complications.
| Total n = 380 | UW n = 267 | CS n = 83 | HTK n = 7 | IGL-1 n = 23 | P | |
|---|---|---|---|---|---|---|
| Pancreas | ||||||
| Abdominal hemorrhage | 32 (8.4) | 24 (8.9) | 7 (8.4) | 1 (14.3) | 0.133 a | |
| Clavien-Dindo | ||||||
| I | 1 (3.1) | 1 (4.2) | 0.150 b | |||
| II | 3 (9.4) | 1 (4.2) | 2 (28.6) | 0.876 c | ||
| IIIa | ||||||
| IIIb | 28 (87.5) | 22 (91.6) | 5 (71.4) | 1 (100) | ||
| IV | ||||||
| Graft pancreatitis | 14 (3.7)* | 8 (3) | 2 (2.4) | 3 (43) | 1 (4.3) | |
| Clavien-Dindo | ||||||
| I | 1 (7.1) | 1 (100) | 0.720 a | |||
| II | 0.620 b | |||||
| IIIa | 5 (35.7) | 2 (25) | 2 (100) | 1 (100) | 0.779 c | |
| IIIb | ||||||
| IV | ||||||
| Abdominal fluid collection | 10 (2.6) | 7 (2.6) | 3 (3.6) | |||
| Clavien-Dindo | ||||||
| I | 2 (20) | 1 (14.3) | 1 (33.3) | 0.432 a | ||
| II | 2 (20) | 2 (28.6) | 0.355 b | |||
| IIIa | 1 (10) | 1 (33.3) | 0.635 c | |||
| IIIb | 5 (50) | 4 (57.1) | 1 (33.3) | |||
| IV | ||||||
| Intestinal complication | 25 (6.6) | 15 (5.6) | 8 (9.6) | 1 (14.3) | 1 (4.3) | |
| Clavien-Dindo | ||||||
| I | 3 (12) | 1 (6.7) | 2 (25) | 0.798 a | ||
| II | 2 (8) | 1 (12.5) | 1 (100) | 0.421 b | ||
| IIIa | 0.197 c | |||||
| IIIb | 14 (56) | 10 (66.7) | 3 (37.5) | 1 (100) | ||
| IV | 6 (24) | 4 (26–7) | 2 (25) | |||
| Vascular thrombosis** | 78 (20.5) | 57 (21.3) | 17 (20.5) | 4 (17.4) | 0.655 a | |
| Anticoagulation protocol | 23 (29.5) | 20 (35.1) | 3 (17.6) | 0.742 b | ||
| Conservative | 11 (14.1) | 5 (8.8) | 4 (23.5) | 2 (50%) | 0.866 c | |
| anticoagulation | 19 (24.4) | 17 (29.8) | 2 (11.8) | |||
| Interventional radiology | 25 (32.1) | 15 (26.3) | 8 (47.1) | 2 (50%) | ||
| Relaparotomy | ||||||
| Pancreas graft (nº patients) | 83 (21.8) | 58 (21.7) | 21 (25.3) | 1 (14.3) | 3 (13) | 0.327 a |
| Time after transplant (days) | 6 (2–15) | 6.5 (1.7–15) | 4 (1–12.5) | 2 | 19 (3–36) | 0.214 b |
| — | 0.496 c | |||||
| Hospital stay | 15 (11–22) | 14 (11–21) | 15 (12–24) | 30 (11–34) | 13 (11–19) | 0.475 a |
| 0.257 b | ||||||
| 0.384 c | ||||||
Categorical variables are expressed as frequencies (%) and percentages and continuous variables as median and interquartile range (IQR).
Comparison of the analysed variables have been made between UW, CS, and IGL-1, groups. For HTK, group only a descriptive analysis is displayed.
IGL-1, vs. UW
IGL-1, vs. CS
UW, vs. CS.
Include hemoperitoneum, intra-abdominal/subcutaneous hematoma.
*In 8 of the cases an immediate transplantectomy was required, not included in Clavien-Dindo classification.
**Venous and arterial thrombosis.
Anticoagulation protocol (enoxaparin + aspirin).
Conservative Anticoagulation (systemic heparin/acenocoumarol).
UW, indicates University of Wisconsin; CS, Celsior; HTK, Histidine-Tryptophan-Ketoglutarate; IGL-1, Institut Georges Lopez-1.